Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa

Conditions:   Anemia;   Dialysis-dependent Chronic Kidney Disease Interventions:   Drug: Vadadustat;   Drug: Epoetin Alfa;   Drug: Vadadustat TIW Sponsor:   Akebia Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials